Works by Shaverdian, Narek

Results: 27

Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.

Published in:

2017

By:

Narek Shaverdian;
Veruttipong, Darlene;
Wang, Jason;
Kupelian, Patrick;
Steinberg, Michael;
Lee, Percy;
Shaverdian, Narek

Publication type:

journal article

Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.

Published in:

2020

By:

Chan, Shawna T.;
Ruan, Dan;
Shaverdian, Narek;
Raghavan, Govind;
Cao, Minsong;
Lee, Percy

Publication type:

journal article

Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.

Published in:

2018

By:

Raghavan, Govind;
Shaverdian, Narek;
Chan, Shawna;
Chu, Fang-I.;
Lee, Percy

Publication type:

journal article

Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.

Published in:

2016

By:

Shaverdian, Narek;
Veruttipong, Darlene;
Wang, Jason;
Schaue, Dorthe;
Kupelian, Patrick;
Lee, Percy

Publication type:

journal article

A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines.

Published in:

PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013677

By:

Coler, Rhea N.;
Baldwin, Susan L.;
Shaverdian, Narek;
Bertholet, Sylvie;
Reed, Steven J.;
Raman, Vanitha S.;
Xiuhua Lu;
DeVos, Joshua;
Hancock, Kathy;
Katz, Jacqueline M.;
Vedvick, Thomas S.;
Duthie, Malcolm S.;
Clegg, Christopher H.;
Van Hoeven, Neal;
Reed, Steven G.

Publication type:

Article

The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality.

Published in:

2018

By:

Shaverdian, Narek;
Wang, Xiaoyan;
Hegde, John V.;
Aledia, Criselda;
Weidhaas, Joanne B.;
Steinberg, Michael L.;
McCloskey, Susan A.

Publication type:

journal article

Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.

Published in:

2018

By:

Hegde, John V.;
Shaverdian, Narek;
Daly, Megan E.;
Felix, Carol;
Wong, Deborah L.;
Rosove, Michael H.;
Garst, Jordan H.;
Wang, Pin‐Chieh;
Veruttipong, Darlene;
Rao, Shyam;
Fragoso, Ruben C.;
Riess, Jonathan W.;
Steinberg, Michael L.;
Chen, Allen M.;
Wang, Pin-Chieh

Publication type:

journal article

Treatment trends for patients with brain metastases: Does practice reflect the data?

Published in:

2017

By:

Sandler, Kiri A.;
Shaverdian, Narek;
Cook, Ryan R.;
Kishan, Amar U.;
King, Christopher R.;
Yang, Isaac;
Steinberg, Michael L.;
Lee, Percy

Publication type:

journal article

MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.

Published in:

European Journal of Immunology, 2013, v. 43, n. 9, p. 2398, doi. 10.1002/eji.201243124

By:

Orr, Mark T.;
Duthie, Malcolm S.;
Windish, Hillarie Plessner;
Lucas, Elyse A.;
Guderian, Jeffrey A.;
Hudson, Thomas E.;
Shaverdian, Narek;
O'Donnell, Joanne;
Desbien, Anthony L.;
Reed, Steven G.;
Coler, Rhea N.

Publication type:

Article

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39874-8

By:

Alessi, Joao V.;
Ricciuti, Biagio;
Wang, Xinan;
Pecci, Federica;
Di Federico, Alessandro;
Lamberti, Giuseppe;
Elkrief, Arielle;
Rodig, Scott J.;
Lebow, Emily S.;
Eicholz, Jordan E.;
Thor, Maria;
Rimner, Andreas;
Schoenfeld, Adam J.;
Chaft, Jamie E.;
Johnson, Bruce E.;
Gomez, Daniel R.;
Awad, Mark M.;
Shaverdian, Narek

Publication type:

Article

Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors.

Published in:

Journal of Radiosurgery & SBRT, 2023, v. 9, n. 1, p. 63

By:

McMillan, Matthew T.;
Shepherd, Annemarie F.;
Minglei Kang;
Liyong Lin;
Shaverdian, Narek;
Wu, Abraham J.;
Gelblum, Daphna Y.;
Ohri, Nitin;
Lazarev, Stanislav;
Lee Xu;
Chhabra, Arpit M.;
Hasan, Shaakir;
Choi, J. Isabelle;
Gomez, Daniel R.;
Rimner, Andreas;
Haibo Lin;
Simone II, Charles B.

Publication type:

Article

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.

Published in:

Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1253629

By:

Lebow, Emily S.;
Shaverdian, Narek;
Eichholz, Jordan E.;
Kratochvil, Leah B.;
McCune, Megan;
Murciano-Goroff, Yonina R.;
Jee, Justin;
Eng, Juliana;
Chaft, Jamie E.;
Kris, Mark G.;
Kalashnikova, Ekaterina;
Feeney, Jordan;
Scalise, Carly Bess;
Sudhaman, Sumedha;
Palsuledesai, Charuta C.;
Malhotra, Meenakshi;
Krainock, Michael;
Sethi, Himanshu;
Aleshin, Alexey;
Liu, Minetta C.

Publication type:

Article

An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non--Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 520, doi. 10.2967/jnumed.123.266965

By:

Thor, Maria;
Chen Lee;
Lian Sun;
Patel, Purvi;
Apte, Aditya;
Grkovski, Milan;
Shepherd, Annemarie F.;
Gelblum, Daphna Y.;
Wu, Abraham J.;
Simone II, Charles B.;
Chaft, Jamie E.;
Rimner, Andreas;
Gomez, Daniel R.;
Deasy, Joseph O.;
Shaverdian, Narek

Publication type:

Article

Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2018, v. 59, n. 11, p. 1714, doi. 10.2967/jnumed.118.209387

By:

Calais, Jeremie;
Kishan, Amar U.;
Minsong Cao;
Fendler, Wolfgang P.;
Eiber, Matthias;
Herrmann, Ken;
Ceci, Francesco;
Reiter, Robert E.;
Rettig, Matthew B.;
Hegde, John V.;
Shaverdian, Narek;
King, Chris R.;
Steinberg, Michael L.;
Czernin, Johannes;
Nickols, Nicholas G.

Publication type:

Article

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Published in:

Journal of Nuclear Medicine, 2018, v. 59, n. 2, p. 230, doi. 10.2967/jnumed.117.201749

By:

Calais, Jeremie;
Czernin, Johannes;
Minsong Cao;
Kishan, Amar U.;
Hegde, John V.;
Shaverdian, Narek;
Sandler, Kiri;
Fang-I Chu;
King, Chris R.;
Steinberg, Michael L.;
Rauscher, Isabel;
Schmidt-Hegemann, Nina-Sophie;
Poeppel, Thorsten;
Hetkamp, Philipp;
Ceci, Francesco;
Herrmann, Ken;
Fendler, Wolfgang P.;
Eiber, Matthias;
Nickols, Nicholas G.

Publication type:

Article

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.

Published in:

JAMA Network Open, 2023, v. 6, n. 1, p. e2249591, doi. 10.1001/jamanetworkopen.2022.49591

By:

Lebow, Emily S.;
Shepherd, Annemarie;
Eichholz, Jordan E.;
Offin, Michael;
Gelblum, Daphna Y.;
Wu, Abraham J.;
Simone II, Charles B.;
Schoenfeld, Adam J.;
Jones, David R.;
Rimner, Andreas;
Chaft, Jamie E.;
Riaz, Nadeem;
Gomez, Daniel R.;
Shaverdian, Narek

Publication type:

Article

Truthfulness in patient-reported outcomes: factors affecting patients' responses and impact on data quality.

Published in:

Patient Related Outcome Measures, 2019, v. 10, p. 171, doi. 10.2147/PROM.S178344

By:

Chang, Eric M;
Gillespie, Erin F;
Shaverdian, Narek

Publication type:

Article

The Patient's perspective on radiation therapy for anal cancer: Evaluation of expectations and stigma.

Published in:

Cancer Reports, 2023, v. 6, n. 12, p. 1, doi. 10.1002/cnr2.1908

By:

Chaballout, Basil H.;
Chang, Eric M.;
Shaverdian, Narek;
Lee, Percy P.;
Beron, Phillip J.;
Steinberg, Michael L.;
Raldow, Ann C.

Publication type:

Article

The patient's perspective on radiation for rectal cancer: Initial expectations versus actual experience.

Published in:

Cancer Medicine, 2023, v. 12, n. 19, p. 19978, doi. 10.1002/cam4.6541

By:

Chaballout, Basil H.;
Chang, Eric M.;
Shaverdian, Narek;
Lee, Percy P.;
Beron, Phillip J.;
Steinberg, Michael L.;
Raldow, Ann C.

Publication type:

Article

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab.

Published in:

Cancer Medicine, 2020, v. 9, n. 13, p. 4622, doi. 10.1002/cam4.3113

By:

Shaverdian, Narek;
Thor, Maria;
Shepherd, Annemarie F.;
Offin, Michael D.;
Jackson, Andrew;
Wu, Abraham J.;
Gelblum, Daphna Y.;
Yorke, Ellen D.;
Simone, Charles B.;
Chaft, Jamie E.;
Hellmann, Matthew D.;
Gomez, Daniel R.;
Rimner, Andreas;
Deasy, Joseph O.

Publication type:

Article

Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non‐small cell lung cancer radiotherapy.

Published in:

Journal of Applied Clinical Medical Physics, 2021, v. 22, n. 2, p. 42, doi. 10.1002/acm2.13150

By:

Yorke, Ellen D.;
Thor, Maria;
Gelblum, Daphna Y.;
Gomez, Daniel R.;
Rimner, Andreas;
Shaverdian, Narek;
Shepherd, Annemarie F.;
Simone, Charles B.;
Wu, Abraham;
McKnight, Dominique;
Jackson, Andrew

Publication type:

Article

Accelerated 3D bSSFP imaging for treatment planning on an MRI‐guided radiotherapy system.

Published in:

Medical Physics, 2018, v. 45, n. 6, p. 2595, doi. 10.1002/mp.12924

By:

Gao, Yu;
Zhou, Ziwu;
Han, Fei;
Cao, Minsong;
Shaverdian, Narek;
Hegde, John V.;
Bista, Biraj B.;
Steinberg, Michael;
Lee, Percy;
Raldow, Ann;
Low, Daniel A.;
Yang, Yingli;
Hu, Peng

Publication type:

Article

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.

Published in:

JAMA Network Open, 2019, v. 2, n. 2, p. e188006, doi. 10.1001/jamanetworkopen.2018.8006

By:

Kishan, Amar U.;
Dang, Audrey;
Katz, Alan J.;
Mantz, Constantine A.;
Collins, Sean P.;
Aghdam, Nima;
Chu, Fang-I;
Kaplan, Irving D.;
Appelbaum, Limor;
Fuller, Donald B.;
Meier, Robert M.;
Loblaw, D. Andrew;
Cheung, Patrick;
Pham, Huong T.;
Shaverdian, Narek;
Jiang, Naomi;
Yuan, Ye;
Bagshaw, Hilary;
Prionas, Nicolas;
Buyyounouski, Mark K.

Publication type:

Article

Utility of Indium-pentetreotide Scintigraphy in Patients with Neuroendocrine Tumors.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 2, p. 640, doi. 10.1245/s10434-012-2617-7

By:

Shaverdian, Narek;
Pinchot, Scott;
Zarebczan, Barbara;
Gillis, Holly;
Schiro, Adam;
Chen, Herbert

Publication type:

Article

Patient perspectives and treatment regret after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal cancer: Findings from a phase II trial.

Published in:

Head & Neck, 2019, v. 41, n. 8, p. 2768, doi. 10.1002/hed.25760

By:

Shaverdian, Narek;
Hegde, John V.;
Felix, Carol;
Hsu, Sophia;
Basehart, Vincent;
Steinberg, Michael L.;
Chen, Allen M.

Publication type:

Article

Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer.

Published in:

British Journal of Radiology, 2017, v. 90, n. 1071, p. -1, doi. 10.1259/bjr.20160739

By:

Shaverdian, Narek;
Yang, Yingli;
Hu, Peng;
Hart, Steven;
Sheng, Ke;
Lamb, James;
Cao, Minsong;
Agazaryan, Nzhde;
Thomas, David;
Steinberg, Michael;
Low, Daniel A;
Lee, Percy

Publication type:

Article

The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.

Published in:

British Journal of Radiology, 2016, v. 89, n. 1059, p. -1, doi. 10.1259/bjr.20150963

By:

Shaverdian, Narek;
Tenn, Stephen;
Veruttipong, Darlene;
Wang, Jason;
Hegde, John;
Lee, Chul;
Cao, Minsong;
Agazaryan, Nzhde;
Steinberg, Michael;
Kupelian, Patrick;
Lee, Percy

Publication type:

Article

Works by Shaverdian, Narek

Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.

Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.

Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.

Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.

A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines.

The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality.

Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.

Treatment trends for patients with brain metastases: Does practice reflect the data?

MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.

Safety and efficacy of stereotactic body proton therapy for high-risk lung tumors.

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.

An <sup>18</sup>F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non--Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.

Potential Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab.

Truthfulness in patient-reported outcomes: factors affecting patients' responses and impact on data quality.

The Patient's perspective on radiation therapy for anal cancer: Evaluation of expectations and stigma.

The patient's perspective on radiation for rectal cancer: Initial expectations versus actual experience.

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab.

Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non‐small cell lung cancer radiotherapy.

Accelerated 3D bSSFP imaging for treatment planning on an MRI‐guided radiotherapy system.

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.

Utility of Indium-pentetreotide Scintigraphy in Patients with Neuroendocrine Tumors.

Patient perspectives and treatment regret after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal cancer: Findings from a phase II trial.

Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer.

The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.